ConductScience.org, home

Paper4875390

The use of combinations of antimicrobial drugs.

Jawetz E. Annu Rev Pharmacol, 1968. Cited by 118 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The use of combinations of antimicrobial drugs. Papers, record 4875390. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4875390

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The use of combinations of antimicrobial drugs.
PubMed
Journal
Annu Rev Pharmacol
PubMed
Year
1968
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
118
iCite
Revised in PubMed
2019-12-10
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jawetz EE

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
Drug SynergismMajor topic
InfectionsMajor topic
Animals
Drug Antagonism
Drug Resistance, Microbial
Humans
Mutation

Source PubMed

Cited by33

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 118 citations.

PMIDTitleJournalYearIn PapersSource
42,701,178Spectrum meets sustainability: green-validated novel simultaneous assays of antimicrobial fixed dose combination.BMC Chem2026https://conductscience.org/library/papers/42701178PubMed
37,770,760Systematic analysis of drug combinations against Gram-positive bacteria.Nat Microbiol2023https://conductscience.org/library/papers/37770760PubMed
27,531,995Comparison of the In vitro Activity of Five Antimicrobial Drugs against Staphylococcus pseudintermedius and Staphylococcus aureus Biofilms.Front Microbiol2016https://conductscience.org/library/papers/27531995PubMed
26,029,671Sertraline enhances the activity of antimicrobial agents against pathogens of clinical relevance.J Biol Res (Thessalon)2015https://conductscience.org/library/papers/26029671PubMed
24,040,081Combination of alpha-melanocyte stimulating hormone with conventional antibiotics against methicillin resistant Staphylococcus aureus.PLoS One2013https://conductscience.org/library/papers/24040081PubMed
14,982,754Combination antifungal therapy.Antimicrob Agents Chemother2004https://conductscience.org/library/papers/14982754PubMed
12,069,981Pharmacodynamic effects of nitroimidazoles alone and in combination with clarithromycin on Helicobacter pylori.Antimicrob Agents Chemother2002https://conductscience.org/library/papers/12069981PubMed
7,399,713Prediction and significance of synergy between antibiotics used for treatment for gram-negative sepsis.Infection1980https://conductscience.org/library/papers/7399713PubMed
7,041,815Bactericidal activity of trimethoprim alone and in combination with sulfamethoxazole on susceptible and resistant Escherichia coli K-12.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/7041815PubMed
6,859,835In vitro activity of rifampin in combination with oxacillin against Staphylococcus aureus.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6859835PubMed
6,360,040Radiometric macrophage culture assay for rapid evaluation of antileprosy activity of rifampin.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6360040PubMed
6,289,731Comparative synergistic activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, combined with tobramycin, against Pseudomonas aeruginosa.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/6289731PubMed
6,249,191
Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with adenine arabinoside, 5-ethyldeoxyuridine, 5-iododeoxyuridine, and phosphonoacetic acid against herpes simplex virus types 1 and 2.
Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6249191PubMed
5,052,053Combinations of antimicrobials.Calif Med1972https://conductscience.org/library/papers/5052053PubMed
4,984,762In vitro susceptibility of Pseudomonas aeruginosa to carbenicillin and the combination of carbenicillin and gentamicin.Appl Microbiol1969https://conductscience.org/library/papers/4984762PubMed
4,881,984The clinician's approach to drug interactions.Calif Med1968https://conductscience.org/library/papers/4881984PubMed
4,790,933Synergism of vancomycin-gentamicin and vancomycin-streptomycin against enterococci.Antimicrob Agents Chemother1973https://conductscience.org/library/papers/4790933PubMed
4,596,743Clinical significance of in vitro synergism between antibiotics in gram-negative infections.Antimicrob Agents Chemother1972https://conductscience.org/library/papers/4596743PubMed
4,494,488Antibiotic susceptibility of oxacillin-resistant staphylococci.Antimicrob Agents Chemother1972https://conductscience.org/library/papers/4494488PubMed
4,330,314In vitro chemotherapeutic combinations against isoniazid-resistant Mycobacterium tuberculosis and Mycobacterium fortuitum.Appl Microbiol1971https://conductscience.org/library/papers/4330314PubMed

See all 33 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4875390

GET https://conductscience.org/api/papers/v1/4875390/cited_by?page=2